capivasertib
astrazeneca,otsuka
['capivasertib', 'breast']
study #asco22 found that adding investigational #capivasertib to treatment of er+/her2- #metastaticbreastcancer patients who are resistant to #endocrinetherapy improved overall survival. for the latest in women's health and more attend #pmwc22 june 28-30 
Leading precision medicine forum hosting the latest initiatives in #healthcare & #biotech, est. 2009 Register for #PMWC22: https://t.co/66nqDkbFfZ